Web-based Platform for Nutrition Management in Patients With Cancer
NCT07307404 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84
Last updated 2025-12-29
Summary
It is crucial to promptly identify nutritional issues in these patients within the community and provide them with dietary guidance, nutritional counseling, and support. This study will be conducted in communities in Chengdu, Sichuan. Community management teams will register oncology patients, collecting information such as demographic data, tumor type, stage, specific treatment plan, treatment hospital, regularity of hospital admissions, and frequency of independent smartphone use. Registered patients will be screened based on inclusion and exclusion criteria. For those who meet the criteria, the community management team will contact them and recommend the use of a dedicated app developed by the research team. An initial nutritional assessment will also be conducted. Patients identified with nutritional risks will be directly referred to the research team's clinical nutritionists for face-to-face consultations. After additional tests, such as body composition analysis, necessary nutritional education and stepwise nutritional interventions will be provided. These patients will also use the app for dietary monitoring and nutritional guidance. For patients without nutritional risks, the app will be recommended for daily questionnaire completion and activity tracking.
Conditions
- Nutrition
Interventions
- OTHER
-
nutrtion care based on app
Self-Intervention: During the period of staying at home, patients use the app developed by the team for self-intervention, including dietary monitoring and check-ins, nutritional risk assessment, learning of educational knowledge, and online expert consultations. Community Intervention: When nutritional risks are detected, pop-up alerts will notify patients to communicate with the community management team. Patients can seek basic nutritional consultations and receive advice from the community management team. If necessary, the management team will refer patients to relevant higher-level hospital outpatient clinics for further care. If patients experience other issues related to their primary condition, the community management team will refer them to community healthcare providers for consultation and treatment. The community will also organize thematic lectures on nutritional management for cancer patients, with oncologists and nutritionists providing regular voluntary consultation
Sponsors & Collaborators
-
Xingchen Peng
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-30
- Primary Completion
- 2026-10-30
- Completion
- 2027-04-30
Countries
- China
Study Locations
More Related Trials
-
Symptoms Burden in Lung Cancer Patients Undergoing Definitive Chemoradiotherapy: Insights From Electronic Patient-Reported Outcomes
NCT07131670 ·Status: RECRUITING
-
Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma
NCT02603016 ·Status: COMPLETED ·Phase: NA
-
Perioperative Symptom Study of Lung Cancer (CN-PRO-Lung 1)
NCT03341377 ·Status: COMPLETED
-
PET/CT Based Radiomics for Lung Cancer (PERL)
NCT03517306 ·Status: UNKNOWN
-
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
NCT04829708 ·Status: RECRUITING ·Phase: PHASE3
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
NCT04465214 ·Status: COMPLETED
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
Intestinal Microflora in Lung Cancer After Chemotherapy
NCT02771470 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Radiation Therapy on the Body in Patients With Stage III Non-Small Cell Lung Cancer
NCT00530205 ·Status: WITHDRAWN
-
Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma
NCT03641105 ·Status: UNKNOWN
-
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
NCT02407912 ·Status: UNKNOWN ·Phase: NA
-
Precision Diagnosis and Therapy for Early Stage Lung Cancer
NCT02936804 ·Status: UNKNOWN ·Phase: NA
-
Factors Influencing Cancer Patients Participation in Clinical Trials in China.
NCT03412344 ·Status: UNKNOWN
-
A Real-World Study of Treatment Patterns and Effectiveness in MET Mutation-Positive Advanced Lung Cancer
NCT06183762 ·Status: RECRUITING
-
Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma
NCT05185544 ·Status: UNKNOWN
-
Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation
NCT02844400 ·Status: COMPLETED
-
NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer
NCT04986670 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT06073431 ·Status: RECRUITING
-
Effects of Chemotherapy on Muscle Mass and Exercise Performance in Patients With Oesophageal Cancer.
NCT01742312 ·Status: COMPLETED
-
A Smart Self-Management Support Programme (3S) to Improve Quality of Life in Lung Cancer Patients
NCT06377124 ·Status: RECRUITING ·Phase: NA
-
Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study
NCT06216782 ·Status: RECRUITING
-
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
NCT06483295 ·Status: RECRUITING ·Phase: NA
-
Mobile Health Application of Disease Self-Management in Non-Small Cell Lung Cancer Patients During Targeted Therapy
NCT05611450 ·Status: UNKNOWN ·Phase: NA
-
Metformin in Non Small Cell Lung Cancer (NSCLC)
NCT02285855 ·Status: TERMINATED ·Phase: PHASE2